Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e29526f284c0155fd79806c9dd5a1c7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2001-0585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-057 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00783 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-1204 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-246 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2466 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2476 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-0469 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M27-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-24 |
filingDate |
2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9386ab544ecaf5a4f371f90f2bda6f1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f60affcfedb02ab6fdc046c09f6ab5e8 |
publicationDate |
2022-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11291544-B2 |
titleOfInvention |
Delivery platforms, devices, and methods for tricuspid valve repair |
abstract |
Devices and methods for treating tricuspid regurgitation (TR) are provided. A clasp or clamp is used to anchor a TR-treatment device to an existing lead of a pacemaker or an implantable cardioverter defibrillator (ICD) that passes through the tricuspid valve. The TR-treatment device can be a balloon occluder that is adjustable by filling or withdrawing filler material from the occluder through a proximal port implanted in the skin of the patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11653948-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11730591-B2 |
priorityDate |
2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |